# Quality of Life With Arcoxia in Women With Dysmenorrhea (0663-094)

> **NCT00380627** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 337 (—)

## Conditions studied

- Pain

## Interventions

- **DRUG:** MK0663, Arcoxia, etoricoxib / Duration of Treatment: 3 Days

## Key facts

- **NCT ID:** NCT00380627
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09-01
- **Primary completion:** 2006-01-31
- **Final completion:** 2006-01-31
- **Target enrollment:** 337 (—)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00380627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00380627, "Quality of Life With Arcoxia in Women With Dysmenorrhea (0663-094)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00380627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*